Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Levi & Korsinsky Notifies Shareholders of Moderna, Inc.(MRNA) of a Class Action Lawsuit and an Upcoming Deadline
09:02pm, Saturday, 07'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 7, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, fo
NEW YORK, NY / ACCESSSWIRE / September 7, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Moderna, Inc. ("Moderna" or the "Company") (NASDAQ:MRNA) and certain officer
The Schall Law Firm Seeks Investor Participation In A Securities Fraud Case Against Moderna, Inc.
11:00am, Saturday, 07'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or "
Is It Time to Buy August's Worst-Performing Nasdaq Stocks?
04:31am, Saturday, 07'th Sep 2024
Super Micro Computer tumbled on a weak earnings report, a short-seller attack, and a delay in its 10-K filing. Moderna plunged as it slashed its guidance for the year.
Shareholders that lost money on Moderna, Inc. (MRNA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
02:30pm, Friday, 06'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, fo
Investors in Moderna, Inc. Should Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA
11:30am, Friday, 06'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, fo
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or "
MRNA Gets Positive CHMP Opinion for Updated COVID-19 Jab
10:55am, Friday, 06'th Sep 2024
The Committee for Medicinal Products for Human Use recommends marketing authorization for Moderna's updated mRNA COVID-19 jab, Spikevax.
Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRNA
07:15am, Friday, 06'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 6, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, fo
NEW YORK CITY, NY / ACCESSWIRE / September 6, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Moderna
MRNA LAWSUIT ALERT: Levi & Korsinsky Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
05:45am, Friday, 06'th Sep 2024
NEW YORK , Sept. 6, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA) of a class action securities lawsuit.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Moderna, Inc.(MRNA) Shareholders
05:45pm, Thursday, 05'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, fo
Moderna, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MRNA
01:04pm, Thursday, 05'th Sep 2024
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA) of a class action securities lawsuit.
Moderna, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA
12:30pm, Thursday, 05'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, fo
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 and June
